Annual report pursuant to Section 13 and 15(d)

Schedule of Deferred Tax Assets (Details)

v3.10.0.1
Schedule of Deferred Tax Assets (Details) - USD ($)
$ in Thousands
Nov. 30, 2018
Nov. 30, 2017
Nov. 30, 2016
Net operating loss carry forwards $ 8,868 $ 11,893  
Research and development expenses 2,915 1,065  
Employee benefits 181 180  
Property and equipment (47) (61)  
Loans (125) 0  
Deferred income (117) (292)  
Intangible assets (4,142) (5,117)  
Less: Valuation allowance (9,235) (8,358) $ (5,151)
Net deferred tax liabilities $ (1,702) $ (690)